Plenco 573-Black

Product Description

Plenco 573-Black was a phenolic molding compound manufactured by Plenco Plastics (Plastics Engineering Company), a Wisconsin-based manufacturer that produced a broad line of thermoset plastic compounds for industrial applications. Phenolic compounds of this type were engineered for environments demanding high heat resistance, dimensional stability, and mechanical strength — properties that made them attractive to manufacturers producing electrical components, automotive parts, industrial equipment housings, and similar goods requiring materials capable of withstanding sustained thermal and mechanical stress.

Phenolic molding compounds, often referred to as phenol-formaldehyde resins or Bakelite-type materials, were among the earliest synthetic plastics developed for industrial use. Plenco Plastics built its commercial reputation on a diverse catalog of such compounds, each formulated to meet particular performance specifications. Within that catalog, Plenco 573-Black represented a dark-pigmented grade, a coloring approach commonly used in electrical and industrial applications where aesthetic uniformity or heat-absorbing properties were relevant factors in product design.

Plastics Engineering Company supplied its molding compounds to downstream manufacturers — operations that used the raw compound material as a feedstock for compression molding, transfer molding, or injection molding processes. The end-use industries served by these customers spanned electrical manufacturing, automotive supply chains, appliance production, and general industrial fabrication. The specific production years for Plenco 573-Black are not definitively established in publicly available documentation, but phenolic compounds of this category were widely produced and sold through much of the mid-to-late twentieth century, a period during which asbestos-containing additives were commonly incorporated into industrial plastics.

Asbestos Content

Asbestos was used as a functional filler and reinforcing agent in many phenolic molding compounds during the decades when industrial use of the mineral was widespread and largely unregulated. In thermoset plastics, asbestos fibers served specific engineering purposes: they improved heat resistance, reduced thermal expansion, enhanced electrical insulating properties, and contributed mechanical strength to finished molded parts. These characteristics aligned closely with the performance demands placed on phenolic compounds used in electrical and high-temperature industrial applications.

Litigation records document claims that Plenco 573-Black contained asbestos as a component of its formulation. The specific fiber type, percentage by weight, and sourcing details are not established in publicly available product safety disclosures reviewed for this article. However, plaintiffs alleged that the compound, consistent with industry-wide practices for phenolic molding materials of the relevant era, incorporated asbestos in quantities sufficient to create a hazardous exposure risk during handling, processing, and finishing operations.

Asbestos-containing phenolic molding compounds were generally not regulated or labeled as hazardous materials during the primary period of their commercial use. The fibrous mineral was considered an advantageous additive, and awareness of the health risks associated with inhalation of asbestos fibers — mesothelioma, asbestosis, and lung cancer — was actively suppressed or minimized by segments of the asbestos and industrial materials industries. OSHA’s first permissible exposure limits for asbestos were not established until 1971, and more protective standards followed over subsequent decades as the scientific and medical evidence became undeniable.

How Workers Were Exposed

Workers who handled, processed, or worked in proximity to Plenco 573-Black and similar phenolic molding compounds faced potential asbestos fiber exposure through several distinct mechanisms tied to the industrial processes involved in using these materials.

Receiving and Raw Material Handling: Industrial workers who unloaded, inventoried, or transported bags or containers of phenolic molding compound were potentially exposed to dust generated during those handling activities. Bulk phenolic compounds in granular or powder form could release particulate — including asbestos fibers if present in the formulation — when containers were opened, emptied, or disturbed.

Molding and Processing Operations: Compression molding, transfer molding, and related thermoset processing operations involved loading measured quantities of compound into heated molds under pressure. Workers performing these tasks — press operators, mold loaders, and process technicians — handled raw compound material repeatedly throughout their shifts. Dust and particulate generated during loading and press operations represented a potential source of fiber release.

Deflashing and Finishing: Molded phenolic parts typically required post-processing to remove flash — excess material squeezed from mold parting lines during the forming process. Deflashing operations, which involved mechanical trimming, grinding, or tumbling of finished parts, generated fine dust from the cured compound. Plaintiffs alleged that this finishing dust, if the base compound contained asbestos, carried respirable fibers capable of remaining airborne for extended periods in production environments.

Machining and Secondary Operations: Parts made from phenolic compounds were sometimes machined, drilled, or otherwise modified after initial molding. Machining operations on asbestos-containing thermoset plastics are documented as a significant source of airborne fiber exposure because cutting and grinding actions fracture the cured matrix and release embedded fibers.

Bystander Exposure: Workers performing tasks elsewhere in facilities where phenolic molding compounds were processed could be exposed as secondary bystanders if dust from molding, deflashing, or machining operations migrated through shared air handling systems or open plant floors. Litigation records document that bystander exposure claims have been pursued in asbestos litigation involving industrial molding compounds.

Industrial workers generally — a category encompassing press operators, assembly workers, quality control personnel, maintenance staff, and others present in manufacturing environments where phenolic compounds were processed — represent the primary exposed population identified in connection with Plenco 573-Black.

Documented Trust Fund / Legal Options

Plenco 573-Black is classified as a Tier 2 product for purposes of this reference, meaning that legal claims associated with this product have proceeded through civil litigation rather than through an established asbestos bankruptcy trust fund. No Plenco Plastics asbestos bankruptcy trust has been identified in publicly available trust fund documentation reviewed for this article.

Civil Litigation: Litigation records document that claims involving Plenco phenolic molding compounds, including asbestos-related injury allegations, have been pursued through the civil court system. Plaintiffs alleged that exposure to asbestos-containing Plenco compounds caused or contributed to diagnosed conditions including mesothelioma, lung cancer, and asbestosis. In civil litigation, plaintiffs typically must establish the presence of asbestos in the identified product, the nature and duration of their exposure, and the causal relationship between that exposure and their diagnosed illness.

Multi-Defendant Litigation: Asbestos lawsuits involving industrial molding compounds are frequently filed as multi-defendant cases, naming manufacturers of asbestos-containing materials used across a worker’s occupational history. Individuals diagnosed with asbestos-related disease after working with phenolic compounds should work with experienced asbestos litigation counsel to identify all potentially responsible parties across their work history.

Accessing Legal Remedies: Individuals who worked with or around Plenco 573-Black and have received a diagnosis of mesothelioma, asbestosis, or asbestos-related lung cancer should consult with a qualified asbestos attorney. Statutes of limitations for asbestos claims vary by state and typically begin running from the date of diagnosis rather than the date of exposure. Prompt legal consultation helps preserve eligibility for available remedies.

This article is provided for informational and reference purposes. It does not constitute legal advice. Individuals seeking legal assistance should consult a licensed attorney experienced in asbestos litigation.